Solventum Corporation (NYSE:SOLV) 2025 Wells Fargo Healthcare Conference September 5, 2025 10:15 AM EDT
Company Participants
Bryan Hanson – CEO & Director
Wayde McMillan – Chief Financial Officer
Conference Call Participants
Vikramjeet Chopra – Wells Fargo Securities, LLC, Research Division
Presentation
Vikramjeet Chopra
Associate Equity Analyst
Okay. Good morning, everyone. My name is Vik Chopra, part of the medical devices’ equity research team here at Wells Fargo. Pleased to introduce management from Solventum for this session. Joining us from the company are Bryan Hanson, CEO; and Wayde McMillan, CFO. Thank you both for being here.
Bryan Hanson
CEO & Director
Yes. Thanks. Thanks for having us.
Question-and-Answer Session
Vikramjeet Chopra
Wells Fargo Securities, LLC, Research Division
Bryan, let’s talk — start off with a few big picture questions. Talk about your vision for the company over the next 5 to 10 years.
Bryan Hanson
CEO & Director
I think probably the best way to talk about the vision is the same way we’ve been referencing it in the past. We’ve got a significant transformation that we need to put into place. Company’s performance wasn’t where we wanted to be. And so we needed to transform it. And we’ve put that into 3 transformation phases. Interestingly about the phases is they sound like they run in serial process, but they’re actually concurrent. Sometimes it’s in a planning phase. Other times, it’s in an execution phase, but we have 3 different phases, nonetheless. The first one and probably the most important that we’ll continue to move on is all around mission, talent and culture in the organization. So we’re going to be highly focused on continuing to drive the mission that we put into place, which is getting a lot of traction with the organization. We’re also going to continue to evaluate the talent, but we’ve made significant changes already in the capability to be able to stand up the
Read the full article here